These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 10770271)

  • 1. Chronic allograft rejection associated vasculopathy and synthetic biodegradable vascular grafts: a lesson to learn?
    Nieuwenhuis P; Hillebrands JL; Rozing J
    Crit Rev Immunol; 2000; 20(1):85-8. PubMed ID: 10770271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor and recipient contribution to transplant vasculopathy in chronic renal transplant dysfunction.
    Boersema M; Rienstra H; van den Heuvel M; van Goor H; van Luyn MJ; Navis GJ; Popa ER; Hillebrands JL
    Transplantation; 2009 Dec; 88(12):1386-92. PubMed ID: 20029335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neointimal smooth muscle cells in human cardiac allograft coronary artery vasculopathy are of donor origin.
    Atkinson C; Horsley J; Rhind-Tutt S; Charman S; Phillpotts CJ; Wallwork J; Goddard MJ
    J Heart Lung Transplant; 2004 Apr; 23(4):427-35. PubMed ID: 15063402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular smooth muscle cells of recipient origin mediate intimal expansion after aortic allotransplantation in mice.
    Li J; Han X; Jiang J; Zhong R; Williams GM; Pickering JG; Chow LH
    Am J Pathol; 2001 Jun; 158(6):1943-7. PubMed ID: 11395369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a combined heart and carotid artery transplant model to investigate the impact of acute rejection on cardiac allograft vasculopathy.
    Soleimani B; Fu F; Lake P; Shi VC
    J Heart Lung Transplant; 2008 Apr; 27(4):450-6. PubMed ID: 18374883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host bone-marrow cells are a source of donor intimal smooth- muscle-like cells in murine aortic transplant arteriopathy.
    Shimizu K; Sugiyama S; Aikawa M; Fukumoto Y; Rabkin E; Libby P; Mitchell RN
    Nat Med; 2001 Jun; 7(6):738-41. PubMed ID: 11385513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marked inhibition of transplant vascular sclerosis by in vivo-mobilized donor dendritic cells and anti-CD154 mAb.
    Wang Z; Morelli AE; Hackstein H; Kaneko K; Thomson AW
    Transplantation; 2003 Aug; 76(3):562-71. PubMed ID: 12923445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel synthetic selectively degradable vascular prostheses: a preliminary implantation study.
    Izhar U; Schwalb H; Borman JB; Hellener GR; Hotoveli-Salomon A; Marom G; Stern T; Cohn D
    J Surg Res; 2001 Feb; 95(2):152-60. PubMed ID: 11162039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-bone marrow origin of neointimal smooth muscle cells in experimental in-stent restenosis in rats.
    Groenewegen HC; Onuta G; Goris M; Zandvoort A; Zijlstra F; van Gilst WH; Rozing J; de Smet BJ; Roks AJ; Hillebrands JL
    J Vasc Res; 2008; 45(6):493-502. PubMed ID: 18434748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arteriopathy in chronic allograft rejection in liver transplantation.
    Miyagawa-Hayashino A; Tsuruyama T; Haga H; Oike F; Il-Deok K; Egawa H; Hiai H; Tanaka K; Manabe T
    Liver Transpl; 2004 Apr; 10(4):513-9. PubMed ID: 15048794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Aug; 82(4):582-91. PubMed ID: 16958183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect effects of alloantibodies link neointimal and medial remodeling in graft arteriosclerosis.
    Thaunat O; Louedec L; Dai J; Bellier F; Groyer E; Delignat S; Gaston AT; Caligiuri G; Joly E; Plissonnier D; Michel JB; Nicoletti A
    Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2359-65. PubMed ID: 16917106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4(+) T cells.
    Kapessidou Y; Habran C; Buonocore S; Flamand V; Barvais L; Goldman M; Braun MY
    Transplantation; 2006 Mar; 81(5):726-35. PubMed ID: 16534475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low molecular weight fucan prevents transplant coronaropathy in rat cardiac allograft model.
    Alkhatib B; Freguin-Bouilland C; Lallemand F; Henry JP; Litzler PY; Marie JP; Richard V; Thuillez C; Plissonnier D
    Transpl Immunol; 2006 Jun; 16(1):14-9. PubMed ID: 16701171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cryopreservation alters antigenicity of allografts in a porcine model of transplant vasculopathy.
    Solanes N; Rigol M; Castellà M; Khabiri E; Ramírez J; Segalés J; Roqué M; Agustí E; Pérez-Villa F; Roig E; Pomar JL; Sanz G; Heras M
    Transplant Proc; 2004 Dec; 36(10):3288-94. PubMed ID: 15686747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of combined rapamycin/cyclosporine on the changes in pro-fibrotic gene expression that occur during the development of allograft vasculopathy in rats, compared with cyclosporine or rapamycin in isolation.
    Murphy GJ; Bicknell GR; Nicholson ML
    Transpl Int; 2003 May; 16(5):347-53. PubMed ID: 12759727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of angiotensin converting enzyme in neointima after intravascular stent placement.
    Nishibe T; Miyazaki K; Kudo F; Flores J; Miyazaki K; Nagato M; Kumada T; Yasuda K
    Int Angiol; 2002 Sep; 21(3):250-5. PubMed ID: 12384646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tobacco smoke exposure in either the donor or recipient before transplantation accelerates cardiac allograft rejection, vascular inflammation, and graft loss.
    Khanna AK; Xu J; Uber PA; Burke AP; Baquet C; Mehra MR
    Circulation; 2009 Nov; 120(18):1814-21. PubMed ID: 19841304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model.
    Walpoth BH; Zammaretti P; Cikirikcioglu M; Khabiri E; Djebaili MK; Pache JC; Tille JC; Aggoun Y; Morel D; Kalangos A; Hubbell JA; Zisch AH
    J Thorac Cardiovasc Surg; 2007 May; 133(5):1163-70. PubMed ID: 17467424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection.
    Wu GD; Tuan TL; Bowdish ME; Jin YS; Starnes VA; Cramer DV; Barr ML
    Transplantation; 2003 Aug; 76(3):609-14. PubMed ID: 12923453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.